[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2752553A1 - Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation - Google Patents

Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation Download PDF

Info

Publication number
CA2752553A1
CA2752553A1 CA2752553A CA2752553A CA2752553A1 CA 2752553 A1 CA2752553 A1 CA 2752553A1 CA 2752553 A CA2752553 A CA 2752553A CA 2752553 A CA2752553 A CA 2752553A CA 2752553 A1 CA2752553 A1 CA 2752553A1
Authority
CA
Canada
Prior art keywords
antibody
seq
human
chimeric
humanized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2752553A
Other languages
English (en)
Inventor
Hans Hansen
Zhengxing Qu
David M. Goldenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Priority claimed from CA2476166A external-priority patent/CA2476166C/fr
Publication of CA2752553A1 publication Critical patent/CA2752553A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA2752553A 2002-02-14 2003-02-14 Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation Abandoned CA2752553A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35613202P 2002-02-14 2002-02-14
US60/356,132 2002-02-14
US41623202P 2002-10-07 2002-10-07
US60/416,232 2002-10-07
CA2476166A CA2476166C (fr) 2002-02-14 2003-02-14 Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2476166A Division CA2476166C (fr) 2002-02-14 2003-02-14 Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation

Publications (1)

Publication Number Publication Date
CA2752553A1 true CA2752553A1 (fr) 2003-08-21

Family

ID=44789661

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2752553A Abandoned CA2752553A1 (fr) 2002-02-14 2003-02-14 Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation

Country Status (1)

Country Link
CA (1) CA2752553A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013085893A1 (fr) 2011-12-05 2013-06-13 Immunomedics, Inc. Utilisation thérapeutique d'anticorps anti-cd22 pour induire une trogocytose

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013085893A1 (fr) 2011-12-05 2013-06-13 Immunomedics, Inc. Utilisation thérapeutique d'anticorps anti-cd22 pour induire une trogocytose
EP2788020A1 (fr) * 2011-12-05 2014-10-15 Immunomedics, Inc. Utilisation thérapeutique d'anticorps anti-cd22 pour induire une trogocytose
EP2788020A4 (fr) * 2011-12-05 2015-04-29 Immunomedics Inc Utilisation thérapeutique d'anticorps anti-cd22 pour induire une trogocytose
US9192664B2 (en) 2011-12-05 2015-11-24 Immunomedics, Inc. Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
US9475883B2 (en) 2011-12-05 2016-10-25 Immunomedics, Inc. Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
US9663576B2 (en) 2011-12-05 2017-05-30 Immunomedics, Inc. Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
US9963507B2 (en) 2011-12-05 2018-05-08 Immunomedics, Inc. Therapeutic use of anti-CD22 antibodies for inducing trogocytosis

Similar Documents

Publication Publication Date Title
CA2476166C (fr) Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation
US9605071B2 (en) Anti-CD19 antibodies
US9184781B2 (en) Humanized antibodies and methods of humanizing antibodies
US7462352B2 (en) Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
CA2752553A1 (fr) Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20190802